Target Binding Site Detail
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T40474 | Target Info | |||
| Target Name | Proto-oncogene c-Met (MET) | ||||
| Synonyms | Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase | ||||
| Target Type | Successful Target | ||||
| Gene Name | MET | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Ligand General Information | Top | ||||
|---|---|---|---|---|---|
| Ligand Name | gamma-butyrolactone | Ligand Info | |||
| Canonical SMILES | C1CC(=O)OC1 | ||||
| InChI | 1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2 | ||||
| InChIKey | YEJRWHAVMIAJKC-UHFFFAOYSA-N | ||||
| PubChem Compound ID | 7302 | ||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| PDB ID: 3F66 Human c-Met Kinase in complex with quinoxaline inhibitor | ||||||
| Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | No | [1] |
| PDB Sequence |
HIDLSALNPE
1061 LVQAVQHVVI1071 GPSSLIVHFN1081 EVIGRGHFGC1091 VYHGTLLKIH1106 CAVKSLNRIT 1116 DIGEVSQFLT1126 EGIIMKDFSH1136 PNVLSLLGIC1146 LRSEGSPLVV1156 LPYMKHGDLR 1166 NFIRNETHNP1176 TVKDLIGFGL1186 QVAKGMKYLA1196 SKKFVHRDLA1206 ARNCMLDEKF 1216 TVKVADFGLA1226 RDMYDKEYYS1236 VAKLPVKWMA1251 LESLQTQKFT1261 TKSDVWSFGV 1271 LLWELMTRGA1281 PPYPDVNTFD1291 ITVYLLQGRR1301 LLQPEYCPDP1311 LYEVMLKCWH 1321 PKAEMRPSFS1331 ELVSRISAIF1341 STFIGEHY
|
|||||
|
|
MET1131
3.459
LEU1140
3.014
SER1141
3.949
LEU1142
3.677
LEU1157
3.757
PHE1168
3.404
HIS1174
4.408
ASN1175
4.232
PRO1176
3.540
ASP1180
3.506
PHE1184
3.468
|
|||||
| PDB ID: 2WD1 Human c-Met Kinase in complex with azaindole inhibitor | ||||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [2] |
| PDB Sequence |
LSALNPELVQ
1064 AVQHVVIGPS1074 SLIVHFNEVI1084 GRGHFGCVYH1094 GTLLDNDGKK1104 IHCAVKSLNR 1114 ITDIGEVSQF1124 LTEGIIMKDF1134 SHPNVLSLLG1144 ICLRSPLVVL1157 PYMKHGDLRN 1167 FIRNETHNPT1177 VKDLIGFGLQ1187 VAKGMKYLAS1197 KKFVHRDLAA1207 RNCMLDEKFT 1217 VKVADFGLAR1227 DMYDKEYYSV1237 HNKTGAKLPV1247 KWMALESLQT1257 QKFTTKSDVW 1267 SFGVLLWELM1277 TRGAPPYPDV1287 NTFDITVYLL1297 QGRRLLQPEY1307 CPDPLYEVML 1317 KCWHPKAEMR1327 PSFSELVSRI1337 SAIFSTFIG
|
|||||
|
|
||||||
| PDB ID: 4R1V Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors | ||||||
| Method | X-ray diffraction | Resolution | 1.20 Å | Mutation | No | [3] |
| PDB Sequence |
LSALNPELVQ
1064 AVQHVVIGPS1074 SLIVHFNEVI1084 GRGHFGCVYH1094 GTLLDNDGKK1104 IHCAVKSLNR 1114 ITDIGEVSQF1124 LTEGIIMKDF1134 SHPNVLSLLG1144 ICLRSSPLVV1156 LPYMKHGDLR 1166 NFIRNETHNP1176 TVKDLIGFGL1186 QVAKGMKYLA1196 SKKFVHRDLA1206 ARNCMLDEKF 1216 TVKVADFGLA1226 RDMYDKEYYS1236 VHNKTGAKLP1246 VKWMALESLQ1256 TQKFTTKSDV 1266 WSFGVLLWEL1276 MTRGAPPYPD1286 VNTFDITVYL1296 LQGRRLLQPE1306 YCPDPLYEVM 1316 LKCWHPKAEM1326 RPSFSELVSR1336 ISAIFSTFI
|
|||||
|
|
PHE1089
3.518
MET1131
3.261
LEU1140
3.298
SER1141
3.902
LEU1142
3.857
VAL1155
4.984
LEU1157
3.521
HIS1162
3.578
PHE1168
3.580
ASN1171
2.969
THR1173
4.453
HIS1174
3.543
|
|||||
| PDB ID: 4KNB C-Met in complex with OSI ligand | ||||||
| Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | No | [4] |
| PDB Sequence |
QAVQHVVIGP
1073 SSLIVHFNEV1083 IGRGHFGCVY1093 HGTLLKIHCA1108 VKSLTDIGEV1121 SQFLTEGIIM 1131 KDFSHPNVLS1141 LLGICLRSEG1151 SPLVVLPYMK1161 HGDLRNFIRN1171 ETHNPTVKDL 1181 IGFGLQVAKG1191 MKYLASKKFV1201 HRDLAARNCM1211 LDEKFTVKVA1221 DFGLARDMYD 1231 KEYYSVHNKT1241 GAKLPVKWMA1251 LESLQTQKFT1261 TKSDVWSFGV1271 LLWELMTRGA 1281 PPYPDVNTFD1291 ITVYLLQGRR1301 LLQPEYCPDP1311 LYEVMLKCWH1321 PKAEMRPSFS 1331 ELVSRISAIF1341 STF
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GBL or .GBL2 or .GBL3 or :3GBL;style chemicals stick;color identity;select .A:1168 or .A:1175 or .A:1176 or .A:1180 or .A:1184 or .A:1216 or .A:1331 or .A:1332 or .A:1335; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase. Bioorg Med Chem Lett. 2009 Jan 15;19(2):397-400. | ||||
| REF 2 | Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorg Med Chem Lett. 2009 May 15;19(10):2780-4. | ||||
| REF 3 | Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1597-602. | ||||
| REF 4 | Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4381-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.